Skip to main content
Boards Home | Best Of | Favorites & Replies | Customize | Start a New Board

TMFang4apples

Cory Renauer

TMFang4apples’ Activity

Sat Jan 2

Caps Pick

TMFang4apples made a pick in CAPS. 4:55 PM

Nano-X Imaging Ltd. (NNOX) will Outperform the S&P 500

Caps Pick

TMFang4apples made a pick in CAPS. 4:55 PM

Trillium Therapeutics (TRIL) will Outperform the S&P 500

Thu Dec 31

Caps Pick

TMFang4apples made a pick in CAPS. 11:56 AM

AstraZeneca PLC (AZN) will Outperform the S&P 500

Wed Dec 30

CAPS Underperform Pitch

TMFang4apples wrote about CEL-SCI (CVM) . 11:01 AM

CVM Underperform

looks like a textbook case of a foot-dragging bioturd

Caps Pick

TMFang4apples made a pick in CAPS. 11:01 AM

CEL-SCI (CVM) will Underperform the S&P 500

Mon Dec 28

Caps Pick

TMFang4apples made a pick in CAPS. 3:35 PM

Fulgent Genetics, Inc. (FLGT) will Outperform the S&P 500

Tue Dec 1

CAPS Underperform Pitch Reply

TMFang4apples commented on TMFang4apples's pitch for DNLI. 9:15 AM

I'm ready to take my lumps on this one, with a little explanation. In December 2020, two-and-a-half years after I noticed Denali dragging its feet with DNL151, we should finally see results from a controlled trial, a phase 1b that started last [more]

CAPS Underperform Pitch

TMFang4apples wrote about BioNTech SE (BNTX) . 8:52 AM

BNTX Underperform

Great company, but there's no way co-commercialization of bnt162 is going to support a $30 billion valuation once attention for mRNA fizzles. I still haven't seen any sign from mRNA developers that they've found a way to ensure safe long-term dosing, [more]

Caps Pick

TMFang4apples made a pick in CAPS. 8:52 AM

BioNTech SE (BNTX) will Underperform the S&P 500

Mon Nov 30

Caps Pick

TMFang4apples made a pick in CAPS. 3:57 PM

AbbVie (ABBV) will Outperform the S&P 500

Tue Nov 3

Caps Pick

TMFang4apples made a pick in CAPS. 3:47 PM

Replimune Group, Inc. (REPL) will Outperform the S&P 500

Caps Pick

TMFang4apples made a pick in CAPS. 3:47 PM

Scholar Rock Holding Corp (SRRK) will Outperform the S&P 500

Fri Oct 16

CAPS Underperform Pitch

TMFang4apples wrote about Northwest Biotherapeutics (NWBO) . 1:06 PM

NWBO Underperform

The stinkiest bioturd of all.

Caps Pick

TMFang4apples made a pick in CAPS. 1:06 PM

Northwest Biotherapeutics (NWBO) will Underperform the S&P 500

Mon Sep 28

CAPS Outperform Pitch Reply

TMFang4apples commented on TMFang4apples's pitch for EXAS. 2:33 PM

nope. I was right the first time

Wed Aug 26

Caps Pick

TMFang4apples made a pick in CAPS. 7:32 AM

Spotify Technology (SPOT) will Outperform the S&P 500

Mon Aug 17

Caps Pick

TMFang4apples made a pick in CAPS. 10:18 AM

Sorrento Therapeutics (SRNE) will Underperform the S&P 500

Wed Jul 22

Caps Pick

TMFang4apples made a pick in CAPS. 2:35 PM

Teladoc Health (TDOC) will Outperform the S&P 500

Wed Jul 1

Caps Pick

TMFang4apples made a pick in CAPS. 10:21 AM

CYTODYN INC (CYDY) will Underperform the S&P 500

Tue Jun 23

Caps Pick

TMFang4apples made a pick in CAPS. 9:34 AM

Acadia Pharmaceuticals (ACAD) will Outperform the S&P 500
Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 86.95
Player Rank 8985 out of 68847
Score 3717.58
Score Change Today -23.47
Accuracy 52.91%
Active Picks 56
Total Picks 218
Best Pick KOD (+915.67)
Worst Pick DNLI (-280.38)
Average Score per Pick 17.13
Charms Earned 9
Highest Rated Favorite TMFBiologyFool
Go to TMFang4apples’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFang4apples’ 10 Latest Posts
The Motley Fool respects your privacy and strive to be transparent about our data collection practices. We use your information to customize the site for you, to contact you about your membership, provide you with promotional information, and in aggregate to help us better understand how the service is used. For more details, please review our Privacy Policy.